【用戶】.
【年級】大三上
【評論內容】(3) 錯誤, 對於HCC 之發生率降低尚有爭議, 無高級證據顯示Harrison 20th Edition, chapter 78 Tumors of Liver and biliary tree, p.581 Regarding HCV infection, eradication of hepatitis C results in decreased HCC incidence. Anti-viral therapies achieving a sustained virological response (SVR) in patients with chronic hepatitis prevent the development of advanced stage disease and cirrhosis, hence resulting in a decreased risk of HCC development. However, once cirrhosis is established no high-level evidence suggests that SVR leads to HCC prevention.(4) 錯誤, Harrison 20th Edition, chapter 78 Tumors of Liver and biliary tree, p.581 Additional putative chemopreventive agents have been proposed to reduce HCC incidence in at-risk populations, including statins and metformin. Nonetheless, the evidence is not strong enough to recommend using these therapies in at-risk patients.